Table 1 Summaries of detailed clinical and MRI characteristics of the studied population
Type I | Type II | ||
|---|---|---|---|
(n = 145) | (n = 105) | p value | |
Clinical features | |||
Age (yrs.) | 43.3 ± 13.9 | 54.5 ± 9.9 | 0.00 |
< 30 | 27 (96.4%) | 1 (3.6%) | |
30–50 | 61 (66.3%) | 31 (33.7%) | |
> 50 | 57 (43.8%) | 73 (56.2%) | |
CA125 level (IU/mL) | 206 ± 326 | 843 ± 1141 | 0.00 |
< 35 | 34 (75.6%) | 11 (24.4%) | |
35–200 | 49 (74.2%) | 17 (25.8%) | |
201–500 | 16 (44.4%) | 20 (55.6%) | |
> 500 | 16 (26.7%) | 44 (73.3%) | |
Ki67expression (%) | 19 ± 20 | 36 ± 22 | 0.00 |
< 50 | 117 (63.6%) | 67 (36.4%) | |
50–75 | 12 (30.8%) | 27 (69.2%) | |
> 75 | 2 (22.2%) | 7 (77.8%) | |
FIGO Stage | 0.00 | ||
I | 59 (75.6%) | 19 (24.4%) | |
II | 11 (52.4%) | 10 (47.6%) | |
III | 26 (32.1%) | 55 (67.9%) | |
IV | 1 (8.3%) | 11 (91.7%) | |
MRI features | |||
Maximum diameter (mm) | 112.7 ± 4.9 | 74.7 ± 3.32 | 0.00 |
< 30 | 3 (42.9%) | 4 (57.1%) | |
30–50 | 12 (33.3%) | 24 (66.7%) | |
51–100 | 54 (52.9%) | 48 (47.1%) | |
> 100 | 71 (73.2%) | 26 (26.8%) | |
Component | 0.00 | ||
Solid | 21 (58.3%) | 15 (41.7%) | |
Cyst | 20 (29.9%) | 47 (70.1%) | |
Mixed | 99 (71.2%) | 40 (28.8%) | |
Mean ADC (SD.) × 10−3 s/m2 | 1275.9 (491.9) | 819.4 (222.7) | 0.00 |
Solid | 1086(214) | 814(187) | |
Cyst | 1015(517) | 805(187) | |
Mixed | 1309(507) | 856(242) | |
Septa | 0.01 | ||
Absent | 72 (50.0%) | 72 (50.0%) | |
Present | 68 (70.1%) | 29 (29.9%) | |
High signal on T1WI | 0.00 | ||
Absent | 75 (46.6%) | 86 (53.4%) | |
Present | 65 (81.3%) | 15 (18.7%) | |